Skip to main content
. Author manuscript; available in PMC: 2015 Mar 5.
Published in final edited form as: Vaccine. 2014 Jan 28;32(11):1240–1246. doi: 10.1016/j.vaccine.2014.01.037

Table 2.

Statistically significant differences between treatments detected at the 5% overall confidence level. Treatments with the same letter in a given assay do not show statistically significant differences. “A” represents the group with the highest response; “B” represents the group the second highest response, etc.

Assay
Treatment
(primary:boost)
Fecal
response
Saliva
response
Serum
IgG
Serum
IgA
Serum mIU/mL
(pre- to post-
boost change)
(final
titer)
RBX:SFE A A A B A A B A
RBX:FF A B -*   B C A   B A B
RBX:Hex   B -   B C A   B A B
RBX:RBX     C   B A A A A
RBX:Ctrl     C   B     C   B   B   B
Saline:Ctrl -   B - - - -

RBX = Recombivax, SFE = supercritical fluid extraction, FF = full fat, Hex = hexane, Ctrl = control wafer

*

statistical differences not determined for these treatments